Advertisement

Topics

Ipatasertib Improves PFS in Advanced Triple-Negative Breast Cancer

03:00 EDT 24 Aug 2017 | Cancer Networks

The AKT inhibitor ipatasertib offered improved progression-free survival over placebo when combined with paclitaxel in women with triple-negative breast cancer.

Original Article: Ipatasertib Improves PFS in Advanced Triple-Negative Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Ipatasertib Improves PFS in Advanced Triple-Negative Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...